논문KCI 등재
The Clinical Utility of MicroRNA as a Prognostic Biomarker of Pancreatobiliary Cancers
2
조회
0
다운로드
0
인용
0
참고문헌
참고문헌 (6)
- Ali S, "Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer", Am J Transl Res, 3, pp.28~47 (2010)
- Huang Q, "MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis", Asian Pac J Cancer Prev, 14, pp.829~834 (2013)
- Kojima M, "MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers", PLoS One, 10, pp.e0118220~ (2015)
- Jaihwan Kim, "MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers", Gut and Liver, 10(5), pp.836~841 (2016), 거트앤리버 발행위원회
- Meng F, "Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines", Gastroenterology, 130, pp.2113~2129 (2006)
- Wang LJ, "Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma", Oncotarget, 6, pp.18631~18640 (2015)
관련 논문AI추천
What Is the Next in Developing Model to Predict Survival Outcomes of Resected Pancreatic Cancer?Kang Chang Moo거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제6호Genetic Analysis Can Surrogate the Treatment Strategies in Patients with Pancreatic CancerDong Uk Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제6호Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?Kim Dong Uk거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제1호MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers김재환, 이상협, Ji Kon Ryu, Yong-Tae Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제5호Genomic Landscapes of Pancreatic NeoplasiaLaura D. Wood, Ralph H. Hruban대한병리학회 · Journal of Pathology and Translational Medicine2015 · 제49권 제1호Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?김동욱거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제1호
이 간행물의 다른 논문 (28건)
How Can We Propagate the National Endoscopy Quality Improvement Program and Improve the Quality of Endoscopic Screening?Dong-Hoon Yangpp. 657-658Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages정대영pp. 659-660Nonzero Risk of Hepatocellular Carcinoma Even after Sustained Virological ResponseHyun Woong Leepp. 661-662The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic CancerPaolo Boffetta, Sunil Amin, Aimee L. Lucaspp. 665-671Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future DirectionsSudhakar Kundapur Venkatesh, Cher Heng Tanpp. 672-686
